Clinical Trial Update: A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency [Phase 4]

View source ↗

Summary

A Phase 4 study comparing ferric carboxymaltose to placebo in patients with iron deficiency and chronic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Iron Deficiency

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Vifor Pharma | Conditions: Iron Deficiency, Chronic Heart Failure | Phase 4 | Status: COMPLETED